Purchase of medicines, active substances bupivacaine, bupivacaine+epinephrine, oxycodone+naloxone, methylphenidate, oxycodone, ondansetron, tenecteplase, lidocaine-chlorhexidine

Open

Updated October 16, 2026

Deadline

17 days left

November 03, 2026

Contract Details

Key facts

Buyer: Sihtasutus Ida-Viru Keskhaigla
Estimated value: €136,600
Deadline: November 03, 202617 days left
CPV Code: 33600000-6 — Pharmaceutical products
Procedure: Open procedure
Lots: Divided into lots
Source: Estonian Public Procurement Register

Budget

€136,600

Duration

Not specified

Location

Estonia

Type

Supplies

Market Benchmark

Avg. Winning Price

€92,792

Avg. Bids

2.2

Competition

Low

SME Winners

86%

3,220 tenders analyzed

Original Tender Description

Ravimite, toimeainega bupivakaiin, bupivakaiin+epinefriin, oksükodoon+naloksoon, metüülfenidaat, oksükodoon, ondansetroon, tenekteplaas, lidokaiin-kloorheksidiin ost 24 kuuks

Electronic Submission

Run Risk Analysis

Identify potential risks, inconsistencies, and red flags across all tender documents. Get a detailed risk report with severity levels and mitigation recommendations.

Win Strategy

Get an AI-powered winning strategy tailored to this tender. Includes win probability score, key opportunities and challenges, recommended bid focus areas, competitive positioning insights, and actionable recommendations to maximize your chances.

Competitors

Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.

Requirements & Qualifications

AI extracts and organizes all requirements from tender documents — mandatory qualifications, technical specifications, financial conditions, and submission rules — clearly categorized so you know exactly what's needed to bid.

Basic Requirements

Company registration in EU required
Proven track record in similar projects
Financial stability documentation